Prøve GULL - Gratis
How Tata Motors e-bus run slowed
Mint Mumbai
|October 16, 2025
Tata Motors Ltd lost the crown of being India’s largest e-bus maker this year, as the rare earth magnet crisis flared and the company turned cautious on public tenders.
The maker of Starbus and Ultra sold just 213 units between January and September, down 80% from a year before, a sharp contrast from the previous two years when it led the segment with annual sales above 1,200 units. However, the company has since engaged with the government on magnets, and may reenter the public tender space soon.
Earlier this year, China clamped down on exports of key rare earths that go into permanent magnets used in electric vehicle motors. There are few alternatives for these critical inputs, forcing companies to import fully-made motors, risking their eligibility to secure various local incentives.
The government has since allowed electric truck and bus manufacturers to temporarily import such motors as an interim solution.
The magnet crisis and the public tendering model took a toll on Tata Motors e-bus sales, two executives aware of the matter said.
"There was an impact of the rare earth crisis on the production of the company. Moreover, the company has also had concerns with how state transport units have been looking to procure vehicles, which is pushing the burden of ownership on them," one of the two executives cited above said on the condition of anonymity.
The magnet curbs unfolded while the company was fulfilling a 3,600-bus tender from government-owned Convergence Energy Services Ltd, a Tata Motors spokesperson said.
Denne historien er fra October 16, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

